Skip to main content
Darrell Wilson, MD, Pediatric Endocrinology, Palo Alto, CA

Darrell Mealer Wilson MD


Professor, Pediatrics - Endocrinology and Diabetes, Stanford University Medical Center

Join to View Full Profile
  • 725 Welch RdPalo Alto, CA 94304

  • Phone+1 650-497-8000

Dr. Wilson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Endocrinology, 1980 - 1984
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1977 - 1980
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 1977
  • University of California
    University of CaliforniaB.S., Electrical Engineering, Highest Honors, 1969 - 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1978 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Endocrinology
    American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

  • America’s Best Doctors 1999-2018
  • America's Top Doctors Castle Connolly, 2002-2014
  • Honoree San Francisco Juvenile Diabetes Research Foundation, 2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reactivation of Latent Viruses in Individuals Receiving Rituximab for New Onset Type 1 Diabetes  
    Kroll JL, Beam C, Li S, Viscidi R, Pescovitz M, Weinberg A, the Type 1 Diabetes TrialNet Anti CD-20 Study Group, J Clin Virol, 2/17/2013
  • Epstein Barr and other Herpes Virus Infections in Early Onset Type I Diabetics Treated with Daclizumab and Mycophenolate Mofetil  
    Loechelt BJ, Boulware D, Green M, Baden LR, Gottlieb P, Krause-Steinrauf H, Weinberg A; for the Type I Diabetes TrialNet Daclizumab/Mycophenolic Acid Study Group, Clin Infect Dis, 10/5/2012
  • The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated Evidence  
    Ruedy KJ, Tamborlane WV, for the Juvenile Diabetes Research Foundation The Landmark JDRF Continuous Glucose Monitoring Study Group, J of Cardiovasc Trans Res, 8/1/2012

Books/Book Chapters

Abstracts/Posters

  • Glucose simulators: Ready for Prime Time? (editorial)
    Wilson DM, Diabetes Technology & the 2013 American Control Conference, Therapeutics, Washington, DC, USA, 1/1/1999

Other

  • The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes 
    DirecNet (Wilson DM)
    1/1/2007
  • Book review JAMA, Preventing Childhood Obesity: Health in the Balance 
    Wilson DM
    1/1/2006
  • Book review. Diabetes,: Nestle Nutrition Workshop Series 
    Wilson DM
    1/1/1996

Press Mentions

  • Clinical Startup of the 670G Closed Loop Insulin Delivery System (670Gstartup)
    Clinical Startup of the 670G Closed Loop Insulin Delivery System (670Gstartup)January 7th, 2017

Grant Support

  • Type 1 Diabetes Trialnet At StanfordNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • Clinical Trial: Type 1 Diabetes: Cellcept Alone Or In Combination With DaclizumaNational Center For Research Resources2008
  • Clinical Trial: Trialnet Screening To Assess Risk Of Type 1 DiabetesNational Center For Research Resources2008
  • Clinical Trial: Trial Of Metformin In Obese Adolescentsmetformin In Obese AdolNational Center For Research Resources2008
  • Clinical Trial: Shared Diabetes Trial StudiesNational Center For Research Resources2008

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: